Selected Start-Ups (04/01)
Executive SummaryIn Vivo summarizes the technology of several recently founded companies: BioWisdom Ltd. is an Internet R&D portal to support site users through all phases of drug discovery and development. Cardion AG will focus on heart disease treatment and cell transplantation using its platforms in gene therapy and stem cell technology. EngeneOS Inc. platform combines biological and engineered components to create programmable biomolecular machines. FemtoLink Biotechnologies LLC aims to accelerate its clients' discovery efforts with its integrated platform for molecular diagnostics of proteins, metabolites and DNA. Labnetics Inc. will develop low cost, disposable diagnostics using miniaturized sensor beads encased in silicon wafers. SyneCor LLC is an accelerator for new cardiovascular device companies.
You may also be interested in...
The company has come a long way since gene therapy flop Glybera, and claims best-in-class status for viral vector.
Softening provisions to make EU-wide joint clinical assessments voluntary would make proposed legislation on HTA cooperation redundant, says Eurordis.